Chief Investment Officer, Cavendish Impact Capital
Tony Quinones has been the driving force behind the formation and growth of Cavendish Impact Capital early stage life science fund. Having identified and acquired investment opportunities by managing all aspects of the business development life cycle from initial qualification, market sector analysis, competitor analysis, technology commercialization, and accelerating company growth through strategic business development and partnerships.
One of his most recent investments is Bright Path, which was created to commercialize small scale continuous flow pharmaceutical manufacturing through his work with Cavendish Global and Medicine4All. Mr. Quinones has assembled a multidisciplinary team of blockchain developers, process engineers, medicinal chemists, computational chemists and, life science The teams he has formed have commercialized sophisticated technologies, executed game changing strategies, created breakthrough products in optimizing chemistry to minimize the number of steps needed to produce life-saving medicines.
This panel addresses using high tech and medicine to deal with global and regional health issues, ways to re-engineer the health system to decrease social unrest and ways to work towards global health care access.